

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.58180743 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.58180743 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.25636477 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.25636477 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.75085888 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.17063873 |
| 7 | tryptophan catabolic process (GO:0006569) | 6.07188986 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 6.07188986 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 6.07188986 |
| 10 | kynurenine metabolic process (GO:0070189) | 5.88616842 |
| 11 | glyoxylate metabolic process (GO:0046487) | 5.82194636 |
| 12 | bile acid biosynthetic process (GO:0006699) | 5.80259669 |
| 13 | tryptophan metabolic process (GO:0006568) | 5.71719376 |
| 14 | * L-serine metabolic process (GO:0006563) | 5.62690207 |
| 15 | alpha-linolenic acid metabolic process (GO:0036109) | 5.56822134 |
| 16 | urea metabolic process (GO:0019627) | 5.42687777 |
| 17 | urea cycle (GO:0000050) | 5.42687777 |
| 18 | high-density lipoprotein particle remodeling (GO:0034375) | 5.39472212 |
| 19 | negative regulation of fibrinolysis (GO:0051918) | 5.27900265 |
| 20 | * sulfur amino acid catabolic process (GO:0000098) | 5.27441174 |
| 21 | * cysteine metabolic process (GO:0006534) | 5.26440356 |
| 22 | complement activation, alternative pathway (GO:0006957) | 5.09684153 |
| 23 | regulation of fibrinolysis (GO:0051917) | 5.09134551 |
| 24 | regulation of protein activation cascade (GO:2000257) | 5.08163397 |
| 25 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.06745100 |
| 26 | protein carboxylation (GO:0018214) | 5.06745100 |
| 27 | nitrogen cycle metabolic process (GO:0071941) | 5.00951380 |
| 28 | * serine family amino acid catabolic process (GO:0009071) | 4.96290135 |
| 29 | bile acid metabolic process (GO:0008206) | 4.94503266 |
| 30 | aromatic amino acid family metabolic process (GO:0009072) | 4.91382011 |
| 31 | lysine catabolic process (GO:0006554) | 4.87993112 |
| 32 | lysine metabolic process (GO:0006553) | 4.87993112 |
| 33 | reverse cholesterol transport (GO:0043691) | 4.85459888 |
| 34 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.84624347 |
| 35 | DNA unwinding involved in DNA replication (GO:0006268) | 4.84227374 |
| 36 | protein complex localization (GO:0031503) | 4.76550702 |
| 37 | regulation of complement activation (GO:0030449) | 4.74286429 |
| 38 | * alpha-amino acid catabolic process (GO:1901606) | 4.72582079 |
| 39 | regulation of cholesterol esterification (GO:0010872) | 4.71074431 |
| 40 | plasma lipoprotein particle remodeling (GO:0034369) | 4.65965947 |
| 41 | protein-lipid complex remodeling (GO:0034368) | 4.65965947 |
| 42 | macromolecular complex remodeling (GO:0034367) | 4.65965947 |
| 43 | regulation of translational fidelity (GO:0006450) | 4.65591875 |
| 44 | amino-acid betaine metabolic process (GO:0006577) | 4.64978900 |
| 45 | tyrosine metabolic process (GO:0006570) | 4.62232645 |
| 46 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.60722068 |
| 47 | glycine metabolic process (GO:0006544) | 4.57712094 |
| 48 | regulation of triglyceride catabolic process (GO:0010896) | 4.55428216 |
| 49 | coenzyme catabolic process (GO:0009109) | 4.49172586 |
| 50 | cellular ketone body metabolic process (GO:0046950) | 4.48625654 |
| 51 | nuclear pore complex assembly (GO:0051292) | 4.48019453 |
| 52 | negative regulation of cholesterol transport (GO:0032375) | 4.45835899 |
| 53 | negative regulation of sterol transport (GO:0032372) | 4.45835899 |
| 54 | glutamate metabolic process (GO:0006536) | 4.43519018 |
| 55 | * cellular amino acid catabolic process (GO:0009063) | 4.43359657 |
| 56 | * homocysteine metabolic process (GO:0050667) | 4.41178891 |
| 57 | acylglycerol homeostasis (GO:0055090) | 4.37284763 |
| 58 | triglyceride homeostasis (GO:0070328) | 4.37284763 |
| 59 | phospholipid efflux (GO:0033700) | 4.34137650 |
| 60 | * serine family amino acid metabolic process (GO:0009069) | 4.31505186 |
| 61 | indolalkylamine metabolic process (GO:0006586) | 4.29564828 |
| 62 | cellular biogenic amine catabolic process (GO:0042402) | 4.26654012 |
| 63 | amine catabolic process (GO:0009310) | 4.26654012 |
| 64 | * cellular modified amino acid catabolic process (GO:0042219) | 4.24769766 |
| 65 | imidazole-containing compound metabolic process (GO:0052803) | 4.24537018 |
| 66 | bile acid and bile salt transport (GO:0015721) | 4.22846174 |
| 67 | proline biosynthetic process (GO:0006561) | 4.22290168 |
| 68 | pre-miRNA processing (GO:0031054) | 4.19718711 |
| 69 | cellular protein complex localization (GO:0034629) | 4.17639927 |
| 70 | heterochromatin organization (GO:0070828) | 4.14544151 |
| 71 | ethanol oxidation (GO:0006069) | 4.11825641 |
| 72 | plasma lipoprotein particle clearance (GO:0034381) | 4.10930979 |
| 73 | regulation of gene silencing by RNA (GO:0060966) | 4.10578459 |
| 74 | regulation of posttranscriptional gene silencing (GO:0060147) | 4.10578459 |
| 75 | regulation of gene silencing by miRNA (GO:0060964) | 4.10578459 |
| 76 | cellular glucuronidation (GO:0052695) | 4.10080495 |
| 77 | tetrahydrofolate metabolic process (GO:0046653) | 4.09323811 |
| 78 | low-density lipoprotein particle remodeling (GO:0034374) | 4.08955818 |
| 79 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.08013266 |
| 80 | * serine family amino acid biosynthetic process (GO:0009070) | 4.02791792 |
| 81 | benzene-containing compound metabolic process (GO:0042537) | 4.02089033 |
| 82 | IMP biosynthetic process (GO:0006188) | 4.00006845 |
| 83 | proline metabolic process (GO:0006560) | 3.98781400 |
| 84 | cholesterol efflux (GO:0033344) | 3.96394183 |
| 85 | intestinal cholesterol absorption (GO:0030299) | 3.91300366 |
| 86 | arginine metabolic process (GO:0006525) | 3.91172925 |
| 87 | nuclear pore organization (GO:0006999) | 3.90354559 |
| 88 | short-chain fatty acid metabolic process (GO:0046459) | 3.90213681 |
| 89 | ketone body metabolic process (GO:1902224) | 3.87762953 |
| 90 | plasma lipoprotein particle assembly (GO:0034377) | 3.86419592 |
| 91 | * organic acid catabolic process (GO:0016054) | 3.84861719 |
| 92 | * carboxylic acid catabolic process (GO:0046395) | 3.84861719 |
| 93 | drug catabolic process (GO:0042737) | 3.84423550 |
| 94 | aspartate family amino acid catabolic process (GO:0009068) | 3.83548666 |
| 95 | regulation of cholesterol homeostasis (GO:2000188) | 3.82282880 |
| 96 | histone arginine methylation (GO:0034969) | 3.79697251 |
| 97 | aldehyde catabolic process (GO:0046185) | 3.77589647 |
| 98 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.75366929 |
| 99 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.75171245 |
| 100 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.74645624 |
| 101 | fibrinolysis (GO:0042730) | 3.73782043 |
| 102 | regulation of bile acid biosynthetic process (GO:0070857) | 3.72531254 |
| 103 | acetyl-CoA metabolic process (GO:0006084) | 3.69870982 |
| 104 | cofactor catabolic process (GO:0051187) | 3.68512285 |
| 105 | folic acid-containing compound metabolic process (GO:0006760) | 3.67685973 |
| 106 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.64425684 |
| 107 | glucuronate metabolic process (GO:0019585) | 3.63299038 |
| 108 | uronic acid metabolic process (GO:0006063) | 3.63299038 |
| 109 | DNA strand elongation (GO:0022616) | 3.62403400 |
| 110 | cholesterol homeostasis (GO:0042632) | 3.61937096 |
| 111 | DNA replication initiation (GO:0006270) | 3.61736237 |
| 112 | complement activation, classical pathway (GO:0006958) | 3.61380491 |
| 113 | phospholipid homeostasis (GO:0055091) | 3.61099433 |
| 114 | IMP metabolic process (GO:0046040) | 3.60237565 |
| 115 | complement activation (GO:0006956) | 3.56666939 |
| 116 | sterol homeostasis (GO:0055092) | 3.56342109 |
| 117 | plasma lipoprotein particle organization (GO:0071827) | 3.55599605 |
| 118 | blood coagulation, intrinsic pathway (GO:0007597) | 3.54729745 |
| 119 | urate metabolic process (GO:0046415) | 3.54525303 |
| 120 | protein localization to kinetochore (GO:0034501) | 3.54119368 |
| 121 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.53920973 |
| 122 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.53920973 |
| 123 | protein activation cascade (GO:0072376) | 3.52897892 |
| 124 | drug transmembrane transport (GO:0006855) | 3.52419558 |
| 125 | cytolysis (GO:0019835) | 3.52065942 |
| 126 | monocarboxylic acid catabolic process (GO:0072329) | 3.50411873 |
| 127 | protein localization to chromosome, centromeric region (GO:0071459) | 3.37733497 |
| 128 | paraxial mesoderm development (GO:0048339) | 3.35191387 |
| 129 | DNA replication checkpoint (GO:0000076) | 3.29290164 |
| 130 | mitotic chromosome condensation (GO:0007076) | 3.28358889 |
| 131 | establishment of integrated proviral latency (GO:0075713) | 3.27835741 |
| 132 | regulation of plasminogen activation (GO:0010755) | 3.22578292 |
| 133 | pore complex assembly (GO:0046931) | 3.15944679 |
| 134 | mitotic sister chromatid segregation (GO:0000070) | 3.15597969 |
| 135 | folic acid metabolic process (GO:0046655) | 3.15510516 |
| 136 | nucleobase biosynthetic process (GO:0046112) | 3.15114483 |
| 137 | peptidyl-arginine N-methylation (GO:0035246) | 3.11694321 |
| 138 | peptidyl-arginine methylation (GO:0018216) | 3.11694321 |
| 139 | purine nucleobase biosynthetic process (GO:0009113) | 3.08456216 |
| 140 | protein-DNA complex disassembly (GO:0032986) | 3.07548136 |
| 141 | nucleosome disassembly (GO:0006337) | 3.07548136 |
| 142 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.04206121 |
| 143 | glutamine metabolic process (GO:0006541) | 2.99259344 |
| 144 | pteridine-containing compound metabolic process (GO:0042558) | 2.95665400 |
| 145 | sister chromatid segregation (GO:0000819) | 2.94626702 |
| 146 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.91941550 |
| 147 | biotin metabolic process (GO:0006768) | 2.91330888 |
| 148 | convergent extension (GO:0060026) | 2.89320349 |
| 149 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.86728578 |
| 150 | midgut development (GO:0007494) | 2.83723576 |
| 151 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.83246195 |
| 152 | DNA duplex unwinding (GO:0032508) | 2.82519638 |
| 153 | * alpha-amino acid biosynthetic process (GO:1901607) | 2.82032131 |
| 154 | establishment of apical/basal cell polarity (GO:0035089) | 2.77623643 |
| 155 | mitochondrial DNA metabolic process (GO:0032042) | 2.75580597 |
| 156 | chromosome condensation (GO:0030261) | 2.74716822 |
| 157 | mitotic nuclear envelope disassembly (GO:0007077) | 2.72495356 |
| 158 | DNA geometric change (GO:0032392) | 2.69509398 |
| 159 | chromatin assembly (GO:0031497) | 2.69334172 |
| 160 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.68888491 |
| 161 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.68282814 |
| 162 | tRNA aminoacylation for protein translation (GO:0006418) | 2.65089063 |
| 163 | negative regulation of histone methylation (GO:0031061) | 2.64547961 |
| 164 | chromatin assembly or disassembly (GO:0006333) | 2.62571703 |
| 165 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.60767075 |
| 166 | rRNA transcription (GO:0009303) | 2.60411964 |
| 167 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.59391391 |
| 168 | DNA replication-independent nucleosome organization (GO:0034724) | 2.59391391 |
| 169 | negative regulation of telomerase activity (GO:0051974) | 2.59349480 |
| 170 | DNA topological change (GO:0006265) | 2.59143691 |
| 171 | ribosome biogenesis (GO:0042254) | 2.58933199 |
| 172 | ATP-dependent chromatin remodeling (GO:0043044) | 2.58390251 |
| 173 | formation of translation preinitiation complex (GO:0001731) | 2.58359395 |
| 174 | regulation of stem cell maintenance (GO:2000036) | 2.55944619 |
| 175 | mitochondrial RNA metabolic process (GO:0000959) | 2.55546960 |
| 176 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.55453057 |
| 177 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.54875364 |
| 178 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.54875364 |
| 179 | tRNA aminoacylation (GO:0043039) | 2.54559264 |
| 180 | amino acid activation (GO:0043038) | 2.54559264 |
| 181 | chromatin remodeling at centromere (GO:0031055) | 2.52933578 |
| 182 | CENP-A containing nucleosome assembly (GO:0034080) | 2.51725237 |
| 183 | nuclear envelope disassembly (GO:0051081) | 2.50362589 |
| 184 | membrane disassembly (GO:0030397) | 2.50362589 |
| 185 | regulation of translational elongation (GO:0006448) | 2.49547728 |
| 186 | DNA conformation change (GO:0071103) | 2.48126616 |
| 187 | negative regulation of mRNA processing (GO:0050686) | 2.45254715 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.29306820 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.85864857 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.14112442 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.70356996 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.43822576 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.36879306 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.92188019 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.72104389 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.93547862 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.89773384 |
| 11 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.74853249 |
| 12 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.53503639 |
| 13 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.17116068 |
| 14 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.81542901 |
| 15 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.80216188 |
| 16 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.70095227 |
| 17 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.54151581 |
| 18 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.53223817 |
| 19 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.41023527 |
| 20 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.40915785 |
| 21 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 2.28124730 |
| 22 | * XRN2_22483619_ChIP-Seq_HELA_Human | 2.21985369 |
| 23 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.21908993 |
| 24 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.08736135 |
| 25 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.01739034 |
| 26 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.01026130 |
| 27 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.00762357 |
| 28 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.8141258 |
| 29 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.93811268 |
| 30 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.92693343 |
| 31 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.92693343 |
| 32 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.92693343 |
| 33 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.89650977 |
| 34 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.87796273 |
| 35 | MYC_22102868_ChIP-Seq_BL_Human | 1.86584093 |
| 36 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.86038553 |
| 37 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.81583632 |
| 38 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.78036534 |
| 39 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.75488965 |
| 40 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.73789110 |
| 41 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.70066188 |
| 42 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.63549520 |
| 43 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.61768989 |
| 44 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.58718937 |
| 45 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.56773419 |
| 46 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.56710277 |
| 47 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.56133020 |
| 48 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.53577292 |
| 49 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.47055904 |
| 50 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.46865410 |
| 51 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.46664727 |
| 52 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.45676128 |
| 53 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.42065272 |
| 54 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.41866696 |
| 55 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.39576290 |
| 56 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.38698041 |
| 57 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.37170865 |
| 58 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.37025817 |
| 59 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.35508534 |
| 60 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.35495164 |
| 61 | GATA1_22025678_ChIP-Seq_K562_Human | 1.35217944 |
| 62 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.30651651 |
| 63 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.30571362 |
| 64 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.29688189 |
| 65 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.28668959 |
| 66 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.26715925 |
| 67 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.26212507 |
| 68 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.25409130 |
| 69 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.24889977 |
| 70 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.24631073 |
| 71 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.24397435 |
| 72 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.23325714 |
| 73 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22944402 |
| 74 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.22305284 |
| 75 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.20955920 |
| 76 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.17147166 |
| 77 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.16381978 |
| 78 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.16014628 |
| 79 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.15862668 |
| 80 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.15591497 |
| 81 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.14056993 |
| 82 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.13224254 |
| 83 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.12721010 |
| 84 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.12106192 |
| 85 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.10660397 |
| 86 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.10056428 |
| 87 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.08506205 |
| 88 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.07162529 |
| 89 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.06835145 |
| 90 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.05702676 |
| 91 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.05260827 |
| 92 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.03849519 |
| 93 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.03050712 |
| 94 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.02934922 |
| 95 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.99944862 |
| 96 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.99382232 |
| 97 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.97394802 |
| 98 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95361398 |
| 99 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.94203148 |
| 100 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.93779491 |
| 101 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.93778390 |
| 102 | KAP1_27257070_Chip-Seq_ESCs_Mouse | 0.92646681 |
| 103 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.92528649 |
| 104 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.92226490 |
| 105 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.92039572 |
| 106 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.91440030 |
| 107 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.91340260 |
| 108 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.90372136 |
| 109 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.90091664 |
| 110 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 0.89660311 |
| 111 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.88885944 |
| 112 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.88614239 |
| 113 | * PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.85645159 |
| 114 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.81885661 |
| 115 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.81334174 |
| 116 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.81299648 |
| 117 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.80617525 |
| 118 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.80213823 |
| 119 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.79013337 |
| 120 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.78997835 |
| 121 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.77784698 |
| 122 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.75311632 |
| 123 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.74053580 |
| 124 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.71927916 |
| 125 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.71414404 |
| 126 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.71035990 |
| 127 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.69310658 |
| 128 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.68259514 |
| 129 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.67245560 |
| 130 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.65215396 |
| 131 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.64039215 |
| 132 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.63631770 |
| 133 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.63314728 |
| 134 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.60341937 |
| 135 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.59729049 |
| 136 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.56848589 |
| 137 | AR_20517297_ChIP-Seq_VCAP_Human | 0.56767248 |
| 138 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.56361530 |
| 139 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.55893920 |
| 140 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.55562998 |
| 141 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.55562998 |
| 142 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.55528155 |
| 143 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.55411260 |
| 144 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.55170123 |
| 145 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.54931391 |
| 146 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.54126668 |
| 147 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.53448889 |
| 148 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.52072591 |
| 149 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.51632772 |
| 150 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.51533061 |
| 151 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.51085108 |
| 152 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 0.50973456 |
| 153 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.50892948 |
| 154 | CBP_21632823_ChIP-Seq_H3396_Human | 0.49989228 |
| 155 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.49887305 |
| 156 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.49648744 |
| 157 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.49250124 |
| 158 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.47316777 |
| 159 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.44025294 |
| 160 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.43336521 |
| 161 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.43194845 |
| 162 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.42492180 |
| 163 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.41954777 |
| 164 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.40805565 |
| 165 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.40608288 |
| 166 | * MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.40348435 |
| 167 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.40248789 |
| 168 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.39656728 |
| 169 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.39613659 |
| 170 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.39586858 |
| 171 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.39088817 |
| 172 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.38878562 |
| 173 | GATA1_19941826_ChIP-Seq_K562_Human | 0.38576778 |
| 174 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.38331622 |
| 175 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.37992833 |
| 176 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.37536523 |
| 177 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.37233564 |
| 178 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.37176209 |
| 179 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.36565755 |
| 180 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.35918871 |
| 181 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.35739316 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.16983175 |
| 2 | MP0005360_urolithiasis | 7.41124211 |
| 3 | MP0005365_abnormal_bile_salt | 6.34316354 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 6.33760730 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.83265675 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.29410058 |
| 7 | MP0003252_abnormal_bile_duct | 3.87124509 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.48756424 |
| 9 | MP0005083_abnormal_biliary_tract | 3.44970775 |
| 10 | MP0003693_abnormal_embryo_hatching | 3.38251785 |
| 11 | MP0003111_abnormal_nucleus_morphology | 3.30217448 |
| 12 | MP0009840_abnormal_foam_cell | 3.25843735 |
| 13 | MP0004957_abnormal_blastocyst_morpholog | 3.08322072 |
| 14 | MP0001666_abnormal_nutrient_absorption | 3.06077108 |
| 15 | * MP0005332_abnormal_amino_acid | 2.93797380 |
| 16 | MP0003195_calcinosis | 2.89988602 |
| 17 | MP0010094_abnormal_chromosome_stability | 2.71659698 |
| 18 | MP0003941_abnormal_skin_development | 2.59724132 |
| 19 | MP0008932_abnormal_embryonic_tissue | 2.42789429 |
| 20 | MP0004233_abnormal_muscle_weight | 2.42250041 |
| 21 | MP0004019_abnormal_vitamin_homeostasis | 2.26670575 |
| 22 | MP0010030_abnormal_orbit_morphology | 2.23112750 |
| 23 | MP0001730_embryonic_growth_arrest | 2.18669095 |
| 24 | MP0003868_abnormal_feces_composition | 2.14194522 |
| 25 | MP0003077_abnormal_cell_cycle | 2.13927974 |
| 26 | MP0003191_abnormal_cellular_cholesterol | 2.13265029 |
| 27 | MP0002118_abnormal_lipid_homeostasis | 2.12778174 |
| 28 | * MP0000609_abnormal_liver_physiology | 2.05233096 |
| 29 | MP0003890_abnormal_embryonic-extraembry | 2.04403797 |
| 30 | MP0002138_abnormal_hepatobiliary_system | 2.04051308 |
| 31 | MP0004858_abnormal_nervous_system | 2.03280343 |
| 32 | MP0000566_synostosis | 2.02790281 |
| 33 | MP0000537_abnormal_urethra_morphology | 1.88685737 |
| 34 | MP0008057_abnormal_DNA_replication | 1.86173081 |
| 35 | MP0002249_abnormal_larynx_morphology | 1.83174221 |
| 36 | MP0005319_abnormal_enzyme/_coenzyme | 1.79909087 |
| 37 | MP0004185_abnormal_adipocyte_glucose | 1.72741804 |
| 38 | MP0005076_abnormal_cell_differentiation | 1.71316045 |
| 39 | MP0008058_abnormal_DNA_repair | 1.70586112 |
| 40 | MP0003123_paternal_imprinting | 1.70359027 |
| 41 | MP0001764_abnormal_homeostasis | 1.68838048 |
| 42 | MP0005380_embryogenesis_phenotype | 1.68613020 |
| 43 | MP0001672_abnormal_embryogenesis/_devel | 1.68613020 |
| 44 | MP0003937_abnormal_limbs/digits/tail_de | 1.66112519 |
| 45 | MP0002085_abnormal_embryonic_tissue | 1.59766431 |
| 46 | MP0000678_abnormal_parathyroid_gland | 1.56869008 |
| 47 | * MP0002697_abnormal_eye_size | 1.54494445 |
| 48 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.54326025 |
| 49 | MP0003984_embryonic_growth_retardation | 1.53145974 |
| 50 | MP0000350_abnormal_cell_proliferation | 1.50175970 |
| 51 | MP0002088_abnormal_embryonic_growth/wei | 1.47919435 |
| 52 | MP0002084_abnormal_developmental_patter | 1.46940638 |
| 53 | MP0003011_delayed_dark_adaptation | 1.46811227 |
| 54 | MP0001697_abnormal_embryo_size | 1.44355850 |
| 55 | MP0009643_abnormal_urine_homeostasis | 1.40385426 |
| 56 | MP0002080_prenatal_lethality | 1.40363293 |
| 57 | MP0006292_abnormal_olfactory_placode | 1.38788401 |
| 58 | MP0005451_abnormal_body_composition | 1.36890284 |
| 59 | MP0009697_abnormal_copulation | 1.36257485 |
| 60 | MP0003136_yellow_coat_color | 1.32811696 |
| 61 | MP0009703_decreased_birth_body | 1.27268006 |
| 62 | MP0002254_reproductive_system_inflammat | 1.25911067 |
| 63 | MP0004133_heterotaxia | 1.22534425 |
| 64 | MP0002938_white_spotting | 1.22385974 |
| 65 | MP0004197_abnormal_fetal_growth/weight/ | 1.21372246 |
| 66 | MP0002111_abnormal_tail_morphology | 1.21010894 |
| 67 | MP0003567_abnormal_fetal_cardiomyocyte | 1.20644220 |
| 68 | MP0008007_abnormal_cellular_replicative | 1.19185578 |
| 69 | MP0005647_abnormal_sex_gland | 1.18754650 |
| 70 | MP0001293_anophthalmia | 1.18701303 |
| 71 | MP0001849_ear_inflammation | 1.18617395 |
| 72 | MP0000428_abnormal_craniofacial_morphol | 1.14816999 |
| 73 | * MP0003942_abnormal_urinary_system | 1.14495180 |
| 74 | MP0005220_abnormal_exocrine_pancreas | 1.14031853 |
| 75 | * MP0003186_abnormal_redox_activity | 1.13908903 |
| 76 | MP0003119_abnormal_digestive_system | 1.13409817 |
| 77 | MP0000604_amyloidosis | 1.11649323 |
| 78 | MP0003861_abnormal_nervous_system | 1.11059069 |
| 79 | * MP0000598_abnormal_liver_morphology | 1.10521481 |
| 80 | MP0000049_abnormal_middle_ear | 1.09829091 |
| 81 | * MP0002086_abnormal_extraembryonic_tissu | 1.09124469 |
| 82 | MP0003656_abnormal_erythrocyte_physiolo | 1.08717607 |
| 83 | MP0005084_abnormal_gallbladder_morpholo | 1.06537086 |
| 84 | MP0002089_abnormal_postnatal_growth/wei | 0.99453403 |
| 85 | MP0004272_abnormal_basement_membrane | 0.98721322 |
| 86 | MP0010352_gastrointestinal_tract_polyps | 0.97191831 |
| 87 | MP0009764_decreased_sensitivity_to | 0.96119805 |
| 88 | MP0010307_abnormal_tumor_latency | 0.94617700 |
| 89 | MP0001346_abnormal_lacrimal_gland | 0.93633313 |
| 90 | MP0002009_preneoplasia | 0.93458162 |
| 91 | * MP0005636_abnormal_mineral_homeostasis | 0.93356358 |
| 92 | MP0003935_abnormal_craniofacial_develop | 0.92678779 |
| 93 | MP0001299_abnormal_eye_distance/ | 0.92229004 |
| 94 | MP0009763_increased_sensitivity_to | 0.91925292 |
| 95 | MP0003315_abnormal_perineum_morphology | 0.89932266 |
| 96 | MP0002396_abnormal_hematopoietic_system | 0.89362880 |
| 97 | MP0002092_abnormal_eye_morphology | 0.88561968 |
| 98 | MP0008995_early_reproductive_senescence | 0.87181343 |
| 99 | MP0000313_abnormal_cell_death | 0.86688690 |
| 100 | MP0003329_amyloid_beta_deposits | 0.86165142 |
| 101 | * MP0009642_abnormal_blood_homeostasis | 0.85985317 |
| 102 | MP0005670_abnormal_white_adipose | 0.85388278 |
| 103 | MP0003690_abnormal_glial_cell | 0.85218243 |
| 104 | MP0001188_hyperpigmentation | 0.84711516 |
| 105 | * MP0003705_abnormal_hypodermis_morpholog | 0.84702934 |
| 106 | MP0002078_abnormal_glucose_homeostasis | 0.84299378 |
| 107 | MP0006036_abnormal_mitochondrial_physio | 0.84256129 |
| 108 | MP0003385_abnormal_body_wall | 0.82570767 |
| 109 | MP0001915_intracranial_hemorrhage | 0.82355086 |
| 110 | * MP0000432_abnormal_head_morphology | 0.80779814 |
| 111 | MP0000534_abnormal_ureter_morphology | 0.80260293 |
| 112 | MP0002876_abnormal_thyroid_physiology | 0.79938410 |
| 113 | MP0005187_abnormal_penis_morphology | 0.79829208 |
| 114 | MP0005408_hypopigmentation | 0.79040783 |
| 115 | MP0000003_abnormal_adipose_tissue | 0.78160544 |
| 116 | MP0005646_abnormal_pituitary_gland | 0.78007745 |
| 117 | * MP0008469_abnormal_protein_level | 0.77833786 |
| 118 | MP0005376_homeostasis/metabolism_phenot | 0.77195899 |
| 119 | * MP0003115_abnormal_respiratory_system | 0.76465990 |
| 120 | * MP0001286_abnormal_eye_development | 0.74459538 |
| 121 | MP0005535_abnormal_body_temperature | 0.73517970 |
| 122 | MP0003938_abnormal_ear_development | 0.73200844 |
| 123 | MP0002233_abnormal_nose_morphology | 0.72778690 |
| 124 | MP0009765_abnormal_xenobiotic_induced | 0.72750821 |
| 125 | MP0003566_abnormal_cell_adhesion | 0.71952845 |
| 126 | MP0001756_abnormal_urination | 0.70987395 |
| 127 | MP0003755_abnormal_palate_morphology | 0.70941158 |
| 128 | MP0002116_abnormal_craniofacial_bone | 0.70754898 |
| 129 | MP0005501_abnormal_skin_physiology | 0.70720279 |
| 130 | MP0001661_extended_life_span | 0.69264908 |
| 131 | MP0010368_abnormal_lymphatic_system | 0.68823509 |
| 132 | MP0002971_abnormal_brown_adipose | 0.68531323 |
| 133 | MP0002081_perinatal_lethality | 0.68458182 |
| 134 | MP0010630_abnormal_cardiac_muscle | 0.68305112 |
| 135 | MP0004130_abnormal_muscle_cell | 0.67543480 |
| 136 | MP0000762_abnormal_tongue_morphology | 0.66599474 |
| 137 | MP0005334_abnormal_fat_pad | 0.64170098 |
| 138 | MP0005266_abnormal_metabolism | 0.63143235 |
| 139 | MP0005448_abnormal_energy_balance | 0.61645897 |
| 140 | MP0006035_abnormal_mitochondrial_morpho | 0.60787962 |
| 141 | MP0003638_abnormal_response/metabolism_ | 0.59704327 |
| 142 | MP0009384_cardiac_valve_regurgitation | 0.59048771 |
| 143 | MP0000639_abnormal_adrenal_gland | 0.58864173 |
| 144 | MP0002928_abnormal_bile_duct | 0.56683260 |
| 145 | MP0009053_abnormal_anal_canal | 0.53396591 |
| 146 | MP0002136_abnormal_kidney_physiology | 0.53116342 |
| 147 | MP0004043_abnormal_pH_regulation | 0.51454299 |
| 148 | MP0005395_other_phenotype | 0.50337011 |
| 149 | MP0003075_altered_response_to | 0.47497809 |
| 150 | * MP0003953_abnormal_hormone_level | 0.47466478 |
| 151 | MP0002796_impaired_skin_barrier | 0.45626765 |
| 152 | MP0003718_maternal_effect | 0.44703596 |
| 153 | MP0000579_abnormal_nail_morphology | 0.42337633 |
| 154 | MP0005666_abnormal_adipose_tissue | 0.40325792 |
| 155 | MP0002822_catalepsy | 0.39523845 |
| 156 | MP0004264_abnormal_extraembryonic_tissu | 0.39002397 |
| 157 | MP0005058_abnormal_lysosome_morphology | 0.38663760 |
| 158 | MP0009672_abnormal_birth_weight | 0.38127635 |
| 159 | MP0008872_abnormal_physiological_respon | 0.37991457 |
| 160 | MP0008874_decreased_physiological_sensi | 0.37960365 |
| 161 | MP0005248_abnormal_Harderian_gland | 0.37476394 |
| 162 | MP0001944_abnormal_pancreas_morphology | 0.36378000 |
| 163 | MP0002168_other_aberrant_phenotype | 0.35829214 |
| 164 | MP0005166_decreased_susceptibility_to | 0.35487461 |
| 165 | MP0001853_heart_inflammation | 0.35024699 |
| 166 | MP0008873_increased_physiological_sensi | 0.34469292 |
| 167 | MP0004381_abnormal_hair_follicle | 0.33852164 |
| 168 | MP0000230_abnormal_systemic_arterial | 0.33625203 |
| 169 | MP0005464_abnormal_platelet_physiology | 0.32500371 |
| 170 | MP0004782_abnormal_surfactant_physiolog | 0.32228128 |
| 171 | MP0001765_abnormal_ion_homeostasis | 0.32152894 |
| 172 | MP0010234_abnormal_vibrissa_follicle | 0.30665030 |
| 173 | MP0003959_abnormal_lean_body | 0.29646234 |
| 174 | MP0002970_abnormal_white_adipose | 0.28477009 |
| 175 | MP0009115_abnormal_fat_cell | 0.27320672 |
| 176 | MP0002837_dystrophic_cardiac_calcinosis | 0.26763648 |
| 177 | MP0002090_abnormal_vision | 0.25863453 |
| 178 | MP0001881_abnormal_mammary_gland | 0.24852163 |
| 179 | MP0004883_abnormal_blood_vessel | 0.24383040 |
| 180 | MP0005167_abnormal_blood-brain_barrier | 0.22567262 |
| 181 | * MP0002135_abnormal_kidney_morphology | 0.22207586 |
| 182 | MP0003436_decreased_susceptibility_to | 0.20950783 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.37551854 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.26853942 |
| 3 | Deep venous thrombosis (HP:0002625) | 7.00694328 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.57856653 |
| 5 | Xanthomatosis (HP:0000991) | 6.19270701 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 6.18921626 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 6.03986332 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.49884432 |
| 9 | Complement deficiency (HP:0004431) | 5.11026203 |
| 10 | Hyperglycinemia (HP:0002154) | 4.79383140 |
| 11 | Hyperammonemia (HP:0001987) | 4.77411776 |
| 12 | Hypolipoproteinemia (HP:0010981) | 4.65054083 |
| 13 | Ketosis (HP:0001946) | 4.56720205 |
| 14 | Joint hemorrhage (HP:0005261) | 4.48842235 |
| 15 | Hyperglycinuria (HP:0003108) | 4.48371425 |
| 16 | Abnormality of glycine metabolism (HP:0010895) | 4.38187223 |
| 17 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.38187223 |
| 18 | Fat malabsorption (HP:0002630) | 4.34466955 |
| 19 | Abnormality of the common coagulation pathway (HP:0010990) | 4.32956538 |
| 20 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.31353199 |
| 21 | Epidermoid cyst (HP:0200040) | 4.29353079 |
| 22 | Abnormality of methionine metabolism (HP:0010901) | 4.29225477 |
| 23 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.24060130 |
| 24 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.20056007 |
| 25 | Hypoalphalipoproteinemia (HP:0003233) | 4.17770611 |
| 26 | * Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.11709557 |
| 27 | Hypoglycemic coma (HP:0001325) | 4.09096847 |
| 28 | Abnormality of the intrinsic pathway (HP:0010989) | 3.78793129 |
| 29 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.72910305 |
| 30 | Conjugated hyperbilirubinemia (HP:0002908) | 3.70003104 |
| 31 | Birth length less than 3rd percentile (HP:0003561) | 3.67227914 |
| 32 | Abnormality of complement system (HP:0005339) | 3.67218270 |
| 33 | Ketoacidosis (HP:0001993) | 3.51437142 |
| 34 | Steatorrhea (HP:0002570) | 3.40860092 |
| 35 | Hypercholesterolemia (HP:0003124) | 3.40516323 |
| 36 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.39682153 |
| 37 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.31457902 |
| 38 | Delayed CNS myelination (HP:0002188) | 3.29365605 |
| 39 | Cortical dysplasia (HP:0002539) | 3.21501097 |
| 40 | Hyperbilirubinemia (HP:0002904) | 3.21344112 |
| 41 | Abnormality of nucleobase metabolism (HP:0010932) | 3.19210737 |
| 42 | Abnormality of serum amino acid levels (HP:0003112) | 3.19159338 |
| 43 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.17220440 |
| 44 | Gout (HP:0001997) | 3.14242633 |
| 45 | Abnormality of purine metabolism (HP:0004352) | 2.92360953 |
| 46 | Chromsome breakage (HP:0040012) | 2.91201788 |
| 47 | Metabolic acidosis (HP:0001942) | 2.85732078 |
| 48 | Hepatocellular carcinoma (HP:0001402) | 2.83186767 |
| 49 | Choanal stenosis (HP:0000452) | 2.82290483 |
| 50 | Spontaneous abortion (HP:0005268) | 2.80741969 |
| 51 | Dicarboxylic aciduria (HP:0003215) | 2.80557791 |
| 52 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.80557791 |
| 53 | Hypoglycemic seizures (HP:0002173) | 2.75835026 |
| 54 | Increased nuchal translucency (HP:0010880) | 2.75795715 |
| 55 | Lethargy (HP:0001254) | 2.75468225 |
| 56 | Hypochromic microcytic anemia (HP:0004840) | 2.72928897 |
| 57 | Vascular calcification (HP:0004934) | 2.69776885 |
| 58 | Skin nodule (HP:0200036) | 2.68939089 |
| 59 | Hyperacusis (HP:0010780) | 2.50210068 |
| 60 | Systemic lupus erythematosus (HP:0002725) | 2.49336371 |
| 61 | Late onset (HP:0003584) | 2.48633955 |
| 62 | Spastic diplegia (HP:0001264) | 2.46596115 |
| 63 | Reticulocytopenia (HP:0001896) | 2.45557495 |
| 64 | Irritability (HP:0000737) | 2.45125665 |
| 65 | Duplication of thumb phalanx (HP:0009942) | 2.44365917 |
| 66 | Abnormality of cochlea (HP:0000375) | 2.43370570 |
| 67 | Cerebral edema (HP:0002181) | 2.41835691 |
| 68 | Malnutrition (HP:0004395) | 2.40080469 |
| 69 | Neonatal onset (HP:0003623) | 2.39254055 |
| 70 | Cardiovascular calcification (HP:0011915) | 2.37279199 |
| 71 | Hepatoblastoma (HP:0002884) | 2.32763096 |
| 72 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.31317576 |
| 73 | Sensorimotor neuropathy (HP:0007141) | 2.29764744 |
| 74 | Overriding aorta (HP:0002623) | 2.29516751 |
| 75 | Generalized aminoaciduria (HP:0002909) | 2.29455588 |
| 76 | Acanthocytosis (HP:0001927) | 2.29333600 |
| 77 | Abnormal gallbladder morphology (HP:0012437) | 2.29323826 |
| 78 | Mitral stenosis (HP:0001718) | 2.29263816 |
| 79 | Amyloidosis (HP:0011034) | 2.28937902 |
| 80 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.28628980 |
| 81 | Abnormality of alanine metabolism (HP:0010916) | 2.28628980 |
| 82 | Hyperalaninemia (HP:0003348) | 2.28628980 |
| 83 | Enlarged kidneys (HP:0000105) | 2.28436090 |
| 84 | Insomnia (HP:0100785) | 2.25072697 |
| 85 | Glomerulonephritis (HP:0000099) | 2.22659345 |
| 86 | Cholelithiasis (HP:0001081) | 2.21766890 |
| 87 | Vomiting (HP:0002013) | 2.19021824 |
| 88 | Turricephaly (HP:0000262) | 2.17697167 |
| 89 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.17130086 |
| 90 | Selective tooth agenesis (HP:0001592) | 2.16227378 |
| 91 | Absent radius (HP:0003974) | 2.15324893 |
| 92 | Multiple enchondromatosis (HP:0005701) | 2.14153805 |
| 93 | Truncus arteriosus (HP:0001660) | 2.11370475 |
| 94 | Abnormality of the labia minora (HP:0012880) | 2.10292636 |
| 95 | Abnormality of glycolysis (HP:0004366) | 2.10249014 |
| 96 | Dysmetric saccades (HP:0000641) | 2.09954219 |
| 97 | Brushfield spots (HP:0001088) | 2.09402285 |
| 98 | Abnormal lung lobation (HP:0002101) | 2.09178673 |
| 99 | Abnormality of reticulocytes (HP:0004312) | 2.08651368 |
| 100 | Opisthotonus (HP:0002179) | 2.07389023 |
| 101 | Hydroxyprolinuria (HP:0003080) | 2.07365313 |
| 102 | Abnormality of proline metabolism (HP:0010907) | 2.07365313 |
| 103 | Ulnar bowing (HP:0003031) | 2.06327092 |
| 104 | Alkalosis (HP:0001948) | 2.06225061 |
| 105 | * Pancreatitis (HP:0001733) | 2.04368914 |
| 106 | Rickets (HP:0002748) | 2.03782641 |
| 107 | Cholecystitis (HP:0001082) | 2.03492360 |
| 108 | Abnormal gallbladder physiology (HP:0012438) | 2.03492360 |
| 109 | Vaginal fistula (HP:0004320) | 2.02661466 |
| 110 | Hyperuricemia (HP:0002149) | 2.02556864 |
| 111 | Increased purine levels (HP:0004368) | 2.02556864 |
| 112 | Partial duplication of thumb phalanx (HP:0009944) | 2.02455564 |
| 113 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.01324200 |
| 114 | Proximal tubulopathy (HP:0000114) | 2.00848436 |
| 115 | Abnormality of the umbilical cord (HP:0010881) | 2.00654631 |
| 116 | Progressive muscle weakness (HP:0003323) | 1.99160998 |
| 117 | * Myocardial infarction (HP:0001658) | 1.98990370 |
| 118 | Absent forearm bone (HP:0003953) | 1.98964475 |
| 119 | Aplasia involving forearm bones (HP:0009822) | 1.98964475 |
| 120 | Embryonal renal neoplasm (HP:0011794) | 1.98949675 |
| 121 | Shallow orbits (HP:0000586) | 1.96919146 |
| 122 | Menorrhagia (HP:0000132) | 1.95875356 |
| 123 | Status epilepticus (HP:0002133) | 1.95653422 |
| 124 | Bowel incontinence (HP:0002607) | 1.94980951 |
| 125 | Gingival bleeding (HP:0000225) | 1.93574187 |
| 126 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.93108452 |
| 127 | Renal duplication (HP:0000075) | 1.92497033 |
| 128 | Abnormal cartilage morphology (HP:0002763) | 1.92133757 |
| 129 | High anterior hairline (HP:0009890) | 1.91249677 |
| 130 | Reticulocytosis (HP:0001923) | 1.91169519 |
| 131 | Abnormality of the gallbladder (HP:0005264) | 1.90140873 |
| 132 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.88522155 |
| 133 | Long palpebral fissure (HP:0000637) | 1.85544342 |
| 134 | Symptomatic seizures (HP:0011145) | 1.85096859 |
| 135 | Abnormal number of incisors (HP:0011064) | 1.83952323 |
| 136 | Hemorrhage of the eye (HP:0011885) | 1.83886838 |
| 137 | Breast hypoplasia (HP:0003187) | 1.83781606 |
| 138 | Abnormality of vitamin metabolism (HP:0100508) | 1.83769740 |
| 139 | Hypophosphatemic rickets (HP:0004912) | 1.83480408 |
| 140 | Back pain (HP:0003418) | 1.83325100 |
| 141 | Increased serum pyruvate (HP:0003542) | 1.82054069 |
| 142 | Glycosuria (HP:0003076) | 1.80581700 |
| 143 | Abnormality of urine glucose concentration (HP:0011016) | 1.80581700 |
| 144 | Abnormal large intestine physiology (HP:0012700) | 1.80511528 |
| 145 | Abnormality of the calcaneus (HP:0008364) | 1.80473460 |
| 146 | Renal cortical cysts (HP:0000803) | 1.80376663 |
| 147 | Pseudobulbar signs (HP:0002200) | 1.80168177 |
| 148 | Thin ribs (HP:0000883) | 1.79620927 |
| 149 | Neonatal hypoglycemia (HP:0001998) | 1.79380036 |
| 150 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.78912691 |
| 151 | Single umbilical artery (HP:0001195) | 1.78912691 |
| 152 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.78912691 |
| 153 | Preauricular skin tag (HP:0000384) | 1.78630576 |
| 154 | Acute hepatic failure (HP:0006554) | 1.76937941 |
| 155 | Asymmetry of the thorax (HP:0001555) | 1.75686600 |
| 156 | Bronchomalacia (HP:0002780) | 1.74307953 |
| 157 | Renovascular hypertension (HP:0100817) | 1.73189771 |
| 158 | Elfin facies (HP:0004428) | 1.71396644 |
| 159 | Septate vagina (HP:0001153) | 1.70602913 |
| 160 | Arnold-Chiari malformation (HP:0002308) | 1.70422409 |
| 161 | Megaloblastic anemia (HP:0001889) | 1.70121201 |
| 162 | Abnormal ventriculo-arterial connection (HP:0011563) | 1.69263118 |
| 163 | Transposition of the great arteries (HP:0001669) | 1.69263118 |
| 164 | Abnormal connection of the cardiac segments (HP:0011545) | 1.69263118 |
| 165 | Morphological abnormality of the inner ear (HP:0011390) | 1.69006173 |
| 166 | Partial duplication of the phalanx of hand (HP:0009999) | 1.68275864 |
| 167 | Calcaneovalgus deformity (HP:0001848) | 1.67493293 |
| 168 | Bifid scrotum (HP:0000048) | 1.66950637 |
| 169 | Embryonal neoplasm (HP:0002898) | 1.66678040 |
| 170 | Horseshoe kidney (HP:0000085) | 1.65647462 |
| 171 | Coronal craniosynostosis (HP:0004440) | 1.65240984 |
| 172 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.63959728 |
| 173 | Hyperthyroidism (HP:0000836) | 1.62680496 |
| 174 | Abnormality of subcutaneous fat tissue (HP:0001001) | 1.61517175 |
| 175 | Hemangiomatosis (HP:0007461) | 1.61444471 |
| 176 | Abnormality of the carotid arteries (HP:0005344) | 1.61266001 |
| 177 | Intestinal fistula (HP:0100819) | 1.61146733 |
| 178 | Hypoparathyroidism (HP:0000829) | 1.60667496 |
| 179 | Flat cornea (HP:0007720) | 1.60322459 |
| 180 | Cheekbone underdevelopment (HP:0010669) | 1.59757906 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.83603252 |
| 2 | EEF2K | 4.73193789 |
| 3 | SIK1 | 4.63306393 |
| 4 | ERN1 | 4.61931688 |
| 5 | FGFR4 | 4.17942486 |
| 6 | SMG1 | 4.10236073 |
| 7 | TAOK3 | 3.31771175 |
| 8 | TTK | 3.24991018 |
| 9 | INSRR | 3.22643716 |
| 10 | CDC7 | 3.18400428 |
| 11 | ERBB4 | 2.61668941 |
| 12 | TRIB3 | 2.54118367 |
| 13 | BUB1 | 2.41594704 |
| 14 | CDK12 | 2.37062301 |
| 15 | VRK2 | 2.32715235 |
| 16 | PKN2 | 2.03096689 |
| 17 | RPS6KB2 | 1.99439017 |
| 18 | SRPK1 | 1.96177851 |
| 19 | LATS1 | 1.93868273 |
| 20 | TSSK6 | 1.92546977 |
| 21 | MST1R | 1.91263765 |
| 22 | MAP2K4 | 1.91185898 |
| 23 | TAF1 | 1.82566174 |
| 24 | MAPK11 | 1.75586119 |
| 25 | CAMK1G | 1.67870938 |
| 26 | LATS2 | 1.65704965 |
| 27 | FLT3 | 1.63568029 |
| 28 | PIK3CG | 1.62595321 |
| 29 | CHEK2 | 1.59647409 |
| 30 | PRKD3 | 1.55358516 |
| 31 | PBK | 1.52620774 |
| 32 | PTK6 | 1.48728734 |
| 33 | CDK7 | 1.41775413 |
| 34 | MAPK15 | 1.34509856 |
| 35 | DAPK2 | 1.33765809 |
| 36 | PINK1 | 1.32574580 |
| 37 | FRK | 1.29479381 |
| 38 | ATR | 1.24899355 |
| 39 | TYK2 | 1.24587912 |
| 40 | NEK1 | 1.24225600 |
| 41 | TYRO3 | 1.24092701 |
| 42 | STK38L | 1.23254246 |
| 43 | FGFR2 | 1.23073717 |
| 44 | NEK2 | 1.22728066 |
| 45 | MKNK1 | 1.21729057 |
| 46 | PLK3 | 1.20366134 |
| 47 | ABL2 | 1.20170867 |
| 48 | WEE1 | 1.17997691 |
| 49 | MAP3K7 | 1.15726844 |
| 50 | PAK4 | 1.13956671 |
| 51 | GRK6 | 1.12952188 |
| 52 | IRAK3 | 1.12231969 |
| 53 | MAP3K8 | 1.11627689 |
| 54 | BRSK1 | 1.10349773 |
| 55 | EIF2AK1 | 1.09397258 |
| 56 | NTRK1 | 1.08455017 |
| 57 | NEK9 | 1.06001076 |
| 58 | JAK2 | 1.02833480 |
| 59 | PRKAA2 | 1.02178493 |
| 60 | MAP3K9 | 1.01725012 |
| 61 | CHEK1 | 1.00690064 |
| 62 | ERBB2 | 0.99056129 |
| 63 | AURKA | 0.98744565 |
| 64 | PLK1 | 0.98407027 |
| 65 | ALK | 0.98017689 |
| 66 | PLK4 | 0.96257053 |
| 67 | EPHA4 | 0.96045780 |
| 68 | DYRK2 | 0.95646649 |
| 69 | KDR | 0.94087814 |
| 70 | MET | 0.93983018 |
| 71 | BRSK2 | 0.93789804 |
| 72 | BRAF | 0.92397254 |
| 73 | PRKCZ | 0.89947543 |
| 74 | KSR2 | 0.88050209 |
| 75 | CDK2 | 0.85307300 |
| 76 | MAPK12 | 0.83480337 |
| 77 | ZAK | 0.82823969 |
| 78 | CDK1 | 0.82128411 |
| 79 | PASK | 0.80996542 |
| 80 | AURKB | 0.80773541 |
| 81 | MAP2K2 | 0.80179874 |
| 82 | NME2 | 0.79907625 |
| 83 | MKNK2 | 0.77488719 |
| 84 | SGK3 | 0.75870171 |
| 85 | MAPK4 | 0.75749392 |
| 86 | BRD4 | 0.74715784 |
| 87 | EPHB1 | 0.73827277 |
| 88 | PRKACG | 0.72503214 |
| 89 | PRKAA1 | 0.71268940 |
| 90 | JAK1 | 0.71122664 |
| 91 | SCYL2 | 0.70874048 |
| 92 | ATM | 0.70486779 |
| 93 | DYRK1B | 0.70474312 |
| 94 | CSNK1E | 0.68131874 |
| 95 | GSK3A | 0.66446643 |
| 96 | FGFR1 | 0.66424091 |
| 97 | SGK2 | 0.66279167 |
| 98 | CAMK2G | 0.65785870 |
| 99 | PTK2 | 0.65690669 |
| 100 | SGK494 | 0.65227177 |
| 101 | SGK223 | 0.65227177 |
| 102 | TBK1 | 0.65124442 |
| 103 | DYRK3 | 0.64929493 |
| 104 | CDK9 | 0.64894241 |
| 105 | RIPK1 | 0.62631462 |
| 106 | MAP3K3 | 0.62203961 |
| 107 | EPHA3 | 0.61914398 |
| 108 | CLK1 | 0.61025216 |
| 109 | LMTK2 | 0.60420710 |
| 110 | NME1 | 0.60191302 |
| 111 | MAP2K6 | 0.59946981 |
| 112 | STK4 | 0.59605049 |
| 113 | MAP3K10 | 0.59463291 |
| 114 | MAPK7 | 0.59417326 |
| 115 | AKT2 | 0.58683224 |
| 116 | CDK6 | 0.58478855 |
| 117 | PRKDC | 0.55020027 |
| 118 | PDPK1 | 0.54734412 |
| 119 | MAP2K1 | 0.54480016 |
| 120 | MAP2K3 | 0.54260991 |
| 121 | PAK2 | 0.53126034 |
| 122 | MAP3K14 | 0.52208453 |
| 123 | MAP3K11 | 0.51810796 |
| 124 | EIF2AK2 | 0.51145435 |
| 125 | CAMK1D | 0.50836677 |
| 126 | RPS6KA1 | 0.50064323 |
| 127 | WNK3 | 0.49683657 |
| 128 | PDK3 | 0.49377281 |
| 129 | PDK4 | 0.49377281 |
| 130 | IRAK2 | 0.49106606 |
| 131 | CSK | 0.48551167 |
| 132 | IRAK1 | 0.48343313 |
| 133 | GSK3B | 0.48029510 |
| 134 | STK3 | 0.47942993 |
| 135 | FGFR3 | 0.47774731 |
| 136 | RPS6KB1 | 0.47231543 |
| 137 | TIE1 | 0.46551748 |
| 138 | PRKCG | 0.45398871 |
| 139 | MAPKAPK5 | 0.45283209 |
| 140 | TAOK2 | 0.43986360 |
| 141 | IGF1R | 0.43353276 |
| 142 | AKT1 | 0.42990023 |
| 143 | WNK4 | 0.42874087 |
| 144 | PHKG2 | 0.42515094 |
| 145 | PHKG1 | 0.42515094 |
| 146 | CDK11A | 0.42485682 |
| 147 | MAPK14 | 0.42448001 |
| 148 | ICK | 0.42118573 |
| 149 | NEK6 | 0.41962095 |
| 150 | CDK15 | 0.41761282 |
| 151 | MTOR | 0.41700013 |
| 152 | GRK1 | 0.40697021 |
| 153 | MAPK10 | 0.40429975 |
| 154 | PRKCQ | 0.39941165 |
| 155 | RAF1 | 0.39100453 |
| 156 | CDK18 | 0.37310107 |
| 157 | CSNK2A2 | 0.36906149 |
| 158 | DAPK1 | 0.36548923 |
| 159 | PIM1 | 0.36087072 |
| 160 | STK38 | 0.33905425 |
| 161 | VRK1 | 0.33842422 |
| 162 | ARAF | 0.33426839 |
| 163 | MUSK | 0.33006528 |
| 164 | AKT3 | 0.32945836 |
| 165 | RET | 0.32443173 |
| 166 | CSNK1G1 | 0.31271572 |
| 167 | PRKCA | 0.29674693 |
| 168 | PDK1 | 0.29421617 |
| 169 | MAP3K2 | 0.28575027 |
| 170 | MAP3K1 | 0.28265494 |
| 171 | CDK4 | 0.27572177 |
| 172 | PIK3CA | 0.27161670 |
| 173 | EGFR | 0.26878669 |
| 174 | EPHA2 | 0.25789931 |
| 175 | PAK3 | 0.25073735 |
| 176 | BMX | 0.24098132 |
| 177 | CSNK1G2 | 0.23627753 |
| 178 | PKN1 | 0.23425281 |
| 179 | PDGFRA | 0.22547660 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.31488668 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.77552322 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.25778972 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.21512927 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.98713008 |
| 6 | DNA replication_Homo sapiens_hsa03030 | 2.81880623 |
| 7 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.70768680 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.67009765 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.66440656 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.64457633 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.57069365 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.56678402 |
| 13 | * Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.56040426 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.53806750 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.25024008 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.17853999 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.09032241 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.07534926 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.01110173 |
| 20 | Mismatch repair_Homo sapiens_hsa03430 | 1.93513865 |
| 21 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.90949210 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.83927154 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.83790096 |
| 24 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.83293458 |
| 25 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.80394375 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.78077449 |
| 27 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.76288650 |
| 28 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.71957485 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.71133843 |
| 30 | Base excision repair_Homo sapiens_hsa03410 | 1.67753287 |
| 31 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.65557658 |
| 32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.61032982 |
| 33 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.60249754 |
| 34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.58842461 |
| 35 | RNA transport_Homo sapiens_hsa03013 | 1.58666569 |
| 36 | Spliceosome_Homo sapiens_hsa03040 | 1.56797240 |
| 37 | Retinol metabolism_Homo sapiens_hsa00830 | 1.56222934 |
| 38 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.53135769 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.52388734 |
| 40 | Bile secretion_Homo sapiens_hsa04976 | 1.49616918 |
| 41 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.49577700 |
| 42 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.48656871 |
| 43 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.47639684 |
| 44 | Cell cycle_Homo sapiens_hsa04110 | 1.45600788 |
| 45 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.43717955 |
| 46 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.42649380 |
| 47 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.39064325 |
| 48 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.35819816 |
| 49 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.34371385 |
| 50 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.34133272 |
| 51 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.33062006 |
| 52 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.30707762 |
| 53 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.27798968 |
| 54 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.24802034 |
| 55 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.22946870 |
| 56 | * Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.22605972 |
| 57 | Thyroid cancer_Homo sapiens_hsa05216 | 1.21016687 |
| 58 | * Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.20042740 |
| 59 | Carbon metabolism_Homo sapiens_hsa01200 | 1.18451766 |
| 60 | ABC transporters_Homo sapiens_hsa02010 | 1.13005188 |
| 61 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.10988761 |
| 62 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.10635059 |
| 63 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.06853961 |
| 64 | Homologous recombination_Homo sapiens_hsa03440 | 1.03239653 |
| 65 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.03028822 |
| 66 | Sulfur relay system_Homo sapiens_hsa04122 | 1.01348515 |
| 67 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.99923287 |
| 68 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.94817380 |
| 69 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.93632520 |
| 70 | Ribosome_Homo sapiens_hsa03010 | 0.88840419 |
| 71 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.83834680 |
| 72 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.82617326 |
| 73 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.82354587 |
| 74 | Lysine degradation_Homo sapiens_hsa00310 | 0.81280429 |
| 75 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.79258420 |
| 76 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.74019898 |
| 77 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.73490054 |
| 78 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.73025790 |
| 79 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.72117682 |
| 80 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.69001895 |
| 81 | RNA polymerase_Homo sapiens_hsa03020 | 0.68775778 |
| 82 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.64120472 |
| 83 | Adherens junction_Homo sapiens_hsa04520 | 0.62990877 |
| 84 | Basal transcription factors_Homo sapiens_hsa03022 | 0.60455878 |
| 85 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.59928686 |
| 86 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.59403415 |
| 87 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.59116254 |
| 88 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58738553 |
| 89 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.51902477 |
| 90 | Bladder cancer_Homo sapiens_hsa05219 | 0.50998350 |
| 91 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.48958978 |
| 92 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.48529099 |
| 93 | RNA degradation_Homo sapiens_hsa03018 | 0.45575931 |
| 94 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.44236730 |
| 95 | Endometrial cancer_Homo sapiens_hsa05213 | 0.42614930 |
| 96 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.41902149 |
| 97 | Tight junction_Homo sapiens_hsa04530 | 0.37876666 |
| 98 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.36528625 |
| 99 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.35573887 |
| 100 | Prostate cancer_Homo sapiens_hsa05215 | 0.35313127 |
| 101 | Purine metabolism_Homo sapiens_hsa00230 | 0.34893329 |
| 102 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.33584124 |
| 103 | Prion diseases_Homo sapiens_hsa05020 | 0.33179624 |
| 104 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.31717601 |
| 105 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.30700236 |
| 106 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.30541814 |
| 107 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.30189853 |
| 108 | Galactose metabolism_Homo sapiens_hsa00052 | 0.29201506 |
| 109 | Insulin resistance_Homo sapiens_hsa04931 | 0.24100039 |
| 110 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.24016307 |
| 111 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22816534 |
| 112 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.18841257 |
| 113 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.18806538 |
| 114 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10666631 |
| 115 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.00958399 |
| 116 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.00294290 |
| 117 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2036046 |
| 118 | Mineral absorption_Homo sapiens_hsa04978 | -0.1988752 |
| 119 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1974704 |
| 120 | Hepatitis C_Homo sapiens_hsa05160 | -0.1935129 |
| 121 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1786276 |
| 122 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1613625 |
| 123 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1456198 |
| 124 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1439227 |
| 125 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1175622 |
| 126 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1111595 |
| 127 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1094531 |
| 128 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1021157 |
| 129 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1019621 |
| 130 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0956633 |
| 131 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0813975 |
| 132 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0689570 |
| 133 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0680594 |
| 134 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0559241 |
| 135 | Pancreatic secretion_Homo sapiens_hsa04972 | -0.0329201 |
| 136 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0150996 |

